Target (CBDY) Times Interest Earned (2014 - 2026)
Target (CBDY) reported Times Interest Earned of -$1.08 for Q1 2026, down 275.54% year-over-year from $0.61 in Q1 2025, and down 10.02% quarter-over-quarter from -$0.98 in Q4 2025.
Target (CBDY) Times Interest Earned (2014 - 2026) Analysis & Trends
Target (CBDY) has 13 years of Times Interest Earned data on file, last reported at -$1.08 in Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$1.08, down 275.54% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.63 (down 157.65% YoY), and the FY2025 annual result was -$0.21, down 121.93% from the prior year.
- Times Interest Earned fell to -$1.08 in Q1 2026 per CBDY's latest filing, from -$0.98 in the prior quarter.
- Over five years, Times Interest Earned peaked at $11526.4 in Q1 2022 and troughed at -$23125.1 in Q1 2023.
- A 5-year average of -$681.99 and a median of $0.28 in 2022 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned jumped 746196.74% in 2022, then slumped 429.87% in 2024.
- A 5-year view of Times Interest Earned shows it stood at $1.88 in 2022, then tumbled by 88.39% to $0.22 in 2023, then soared by 495.04% to $1.3 in 2024, then slumped by 175.11% to -$0.98 in 2025, then retreated by 10.02% to -$1.08 in 2026.
- Business Quant data shows CBDY's Times Interest Earned at -$1.08 in Q1 2026, -$0.98 in Q4 2025, and -$0.96 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.31 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.72 |
| 10 | Target | - | - | 191,787.00 | -1.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.08 |
| Dec 31, 2025 | -0.98 |
| Sep 30, 2025 | -0.96 |
| Jun 30, 2025 | 0.52 |
| Mar 31, 2025 | 0.61 |
| Dec 31, 2024 | 1.30 |
| Sep 30, 2024 | -0.89 |
| Jun 30, 2024 | 3.30 |
| Mar 31, 2024 | 0.32 |
| Dec 31, 2023 | 0.22 |
| Sep 30, 2023 | -0.17 |
| Jun 30, 2023 | -0.30 |
| Mar 31, 2023 | -23,125.10 |
| Dec 31, 2022 | 1.88 |
| Sep 30, 2022 | 0.71 |
| Jun 30, 2022 | 0.28 |
| Mar 31, 2022 | 11,526.44 |
| Sep 30, 2021 | -0.25 |
| Jun 30, 2021 | -1.61 |
| Mar 31, 2021 | -1.54 |